Robert A Adler1. 1. McGuire Veterans Affairs Medical Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia 23249, USA. robert.adler@va.gov
Abstract
PURPOSE OF REVIEW: Patients treated for cancer may be at risk for osteoporosis and fracture. Evaluation and treatment of patients with cancer treatment-induced bone loss should lead to fewer fractures. This review will help clinicians learn to identify, evaluate and treat cancer patients at risk. RECENT FINDINGS: Survivors of childhood cancers and patients made hypogonadal by treatment for breast or prostate cancer are clearly at risk for osteoporosis and fracture. Use of aromatase inhibitors rather than tamoxifen for breast cancer will likely lead to more osteoporosis. Bisphosphonates prevent bone loss in many patients at risk. SUMMARY: For many cancer patients, treatment with calcium, vitamin D, and bisphosphonates will likely decrease the consequences of cancer treatment-induced bone loss, namely fractures.
PURPOSE OF REVIEW: Patients treated for cancer may be at risk for osteoporosis and fracture. Evaluation and treatment of patients with cancer treatment-induced bone loss should lead to fewer fractures. This review will help clinicians learn to identify, evaluate and treat cancerpatients at risk. RECENT FINDINGS: Survivors of childhood cancers and patients made hypogonadal by treatment for breast or prostate cancer are clearly at risk for osteoporosis and fracture. Use of aromatase inhibitors rather than tamoxifen for breast cancer will likely lead to more osteoporosis. Bisphosphonates prevent bone loss in many patients at risk. SUMMARY: For many cancerpatients, treatment with calcium, vitamin D, and bisphosphonates will likely decrease the consequences of cancer treatment-induced bone loss, namely fractures.
Authors: Webb A Smith; Vikki G Nolan; Leslie L Robison; Melissa M Hudson; Kirsten K Ness Journal: Am J Transl Res Date: 2011-07-10 Impact factor: 4.060
Authors: Donald L Trump; Manpreet K Chadha; Annette Y Sunga; Marwan G Fakih; Umeer Ashraf; Carrie G Silliman; Bruce W Hollis; Mary K Nesline; Lili Tian; Wei Tan; Candace S Johnson Journal: BJU Int Date: 2009-04-04 Impact factor: 5.588
Authors: Young Lim Oh; Man Soo Yoon; Dong Soo Suh; Ari Kim; Min Joung Kim; Ji Young Lee; Yong Jung Song; Yong Il Ji; Ki Hyung Kim; Sungwook Chun Journal: J Cancer Date: 2015-01-01 Impact factor: 4.207
Authors: Scott C Adams; Jennifer Herman; Iliana C Lega; Laura Mitchell; David Hodgson; Kim Edelstein; Lois B Travis; Catherine M Sabiston; Paaladinesh Thavendiranathan; Abha A Gupta Journal: JNCI Cancer Spectr Date: 2020-10-28